Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049447

EVP & Chief R & QA Officer sold 3,021 shares at $14.33 ($43,291)

  • EVP & Chief R & QA Officer acquired 7,211 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Clark Mitchall G. EVP & Chief R & QA Officer 2017-08-15 Option exercise +7,211 162,151 D
Clark Mitchall G. EVP & Chief R & QA Officer 2017-08-16 Sale −3,021 $14.33 $43,291 159,130 D
Derivatives
Clark Mitchall G. EVP & Chief R & QA Officer 2017-08-15 Option exercise · Restricted Stock Unites −7,211 19,231 D
Open-market sales · 3,021 sh · avg $14.33 · $43,291
Loading xslF345X03/doc4.xml…